Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
FDA Introduces Data Modernization Action Plan
Posted on March 29th, 2021 by Ann-Marie Roche in Pharma R&D
One of the frustrations of our Big Data era is that, despite the existence of an ever-growing wealth of valuable data, this data is often stuck in different silos. This lack of accessibility makes it hard to get the most out of data that has the potential to be extremely useful.
(more…)Elsevier to Work with Heel for Mechanism-based Drug Action Discovery
Posted on January 6th, 2021 by Thea Howe in Pharma R&D
Elsevier, the data analytics business specialized in science and health, and Heel, a pharmaceutical company specialized in developing and manufacturing medicines made from natural ingredients, have recently completed a series of research projects with a focus on improving exploratory preclinical studies.
(more…)Insights begin with clean, reusable data
Posted on August 24th, 2020 by Ani Marrs in Pharma R&D
Good data practices lead to better research outcomes. To learn more about why clean, reusable data is critical to R&D, take a look at this helpful new infographic that demonstrates how Entellect is centered around the importance of reusable data, irrespective of scientific domain.
(more…)The Dawn of a European Health Data Space – Challenges
Posted on July 16th, 2020 by Mark Siebert in Pharma R&D
The European data strategy aims to construct common data spaces for all, create a single EU market for data, and catalyze a dynamic data economy. In a previous post, we briefly described the essence of the envisioned heath data space and pointed at opportunities and possible starting points to transform this vision into reality.
(more…)
